Peters, Danielle Organ
Lobbying
Information
Figures are based on lobbying activity reported to the Senate Office of Public Records. Reported dollar amounts are required to be accurate only to the nearest $20,000. For organizations whose primary business is lobbying, we display total income and top clients. For organizations that are not primarily lobbying firms, we display total amount spent on lobbying and top lobbying firms hired.
For more information, please see our lobbying methodology page.
Lobbying Carried Out by Peters, Danielle Organ
-
Names of Lobbyists
-
Client Amount Nanotherapeutics Inc $0 Alnylam Pharmaceuticals $0 Trius Therapeutics $0 SCYNEXIS Inc $0 Variation Biotechnologies $0 TherOx Inc $0 3-V Biosciences $0 ARCA Biopharma $0 Ocera Therapeutics $0 Medicago $0 -
Most Frequently Disclosed Lobbying Issues
- Health Issues,
- Defense,
- Fed Budget & Appropriations,
- Medical Research & Clin Labs,
- Copyright, Patent & Trademark,
- Veterans Affairs,
- Pharmacy,
- Trade
-
Most Frequently Disclosed Bills
Bill No. Title S.515 Patent Reform Act of 2009 H.R.3590 Service Members Home Ownership Tax Act of 2009 -
Recent Lobbying Contracts
Date Client Summary April 22, 2013 The Conafay Group on behalf of Ziopharm Oncology, Inc. Educated members of the House of Representatives on the importance of encouraging innovation in rare cancer drug development. View registration April 22, 2013 CONAFAY GROUP ON BEHALF OF AWG Public policy to incentivize antibiotic drug development and innovation View registration
